| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.2 | 7e-09 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-08 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.17 | 9e-08 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-07 |